https://www.selleckchem.com/pr....oducts/tak-243-mln24
Although the clinical features and treatment results of Hodgkin lymphoma (HL) in young adults are well known, it is thought that the disease may have different characteristics in elderly patients with HL, which constitutes almost 25% of the group. In this study, our aim is to evaluate the clinicopathological features, treatment outcomes, and survival of elderly classical Hodgkin lymphoma (CHL) patients. Patients aged 60 and over who were treated with a diagnosis of CHL were included in our retrospective cohort study. Patients und
Beğen
Yorum Yap
Paylaş
